Discontinued — last reported Q4 '23
Cigna Home Delivery And Specialty — Revenue increased by 2.8% to $16.79B in Q4 2023 compared to the prior quarter. Year-over-year, this metric grew by 6.7%, from $15.73B to $16.79B. Over 2 years (FY 2021 to FY 2023), Home Delivery And Specialty — Revenue shows an upward trend with a 9.9% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase indicates growth in pharmacy service volume, successful contract wins, or higher utilization of specialty medications, while a decrease may signal contract losses or pricing pressures in the pharmacy benefit management market.
This metric represents the total gross revenue generated from pharmacy benefit management services, including home deliv...
Comparable to pharmacy services revenue reported by other integrated healthcare providers or standalone pharmacy benefit managers, often benchmarked against total pharmacy claims volume and specialty drug spend trends.
ci_segment_home_delivery_and_specialty_revenues_revenues| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $13.01B | $13.52B | $15.40B | $14.70B | $15.27B | $15.58B | $15.73B | $16.03B | $16.59B | $16.32B | $16.79B |
| QoQ Change | — | +3.8% | +14.0% | -4.6% | +3.9% | +2.1% | +1.0% | +1.9% | +3.6% | -1.6% | +2.8% |
| YoY Change | — | — | — | — | +17.3% | +15.3% | +2.1% | +9.0% | +8.7% | +4.8% | +6.7% |